Current Updates in Perioperative Management of Intracerebral Hemorrhage

Patrick C. Hsieh, Issam A. Awad, Christopher C. Getch, Bernard R. Bendok, Szymon S. Rosenblatt, H. Hunt Batjer

Research output: Contribution to journalArticle

14 Citations (Scopus)

Abstract

Spontaneous ICH remains a formidable disease that continues to disable and kill the majority of its victims. Treatment of the disease continues to be controversial and without any proved success, such as improvement in the disease mortality or the resulting disability in survivors. Primary prevention is the most effective medical intervention. Nevertheless, as the population continues to age and patients remain undertreated for hypertension, the incidence of ICH likely will increase, resulting in significant socioeconomic impact on society in the coming years. It is imperative that more research be conducted to improve treatment and outcomes of patients who have ICH. Unlike ischemic stokes or other causes of hemorrhagic stroke, such as SAH, where major advancement of treatment has led to improved outcomes, the increased incidence of ICH has not been matched with any considerable improvement in treatment. This burden to improve therapeutic interventions for patients who have ICH should be shared by all neurosurgeons, stroke neurologists, and critical care physicians who care for these patients on a regular basis. It is hoped that early diagnosis and resuscitation, prevention of hematoma growth, selective surgery or minimally invasive clot evacuation, and judicious critical care and rehabilitation will combine to lessen the burden of this disease.

Original languageEnglish (US)
Pages (from-to)745-764
Number of pages20
JournalNeurologic Clinics
Volume24
Issue number4
DOIs
StatePublished - Nov 2006

Fingerprint

Cerebral Hemorrhage
Critical Care
Stroke
Minimally Invasive Surgical Procedures
Incidence
Primary Prevention
Therapeutics
Resuscitation
Hematoma
Survivors
Early Diagnosis
Patient Care
Rehabilitation
Hypertension
Physicians
Mortality
Growth
Research
Population

ASJC Scopus subject areas

  • Clinical Neurology

Cite this

Hsieh, P. C., Awad, I. A., Getch, C. C., Bendok, B. R., Rosenblatt, S. S., & Batjer, H. H. (2006). Current Updates in Perioperative Management of Intracerebral Hemorrhage. Neurologic Clinics, 24(4), 745-764. https://doi.org/10.1016/j.ncl.2006.05.005

Current Updates in Perioperative Management of Intracerebral Hemorrhage. / Hsieh, Patrick C.; Awad, Issam A.; Getch, Christopher C.; Bendok, Bernard R.; Rosenblatt, Szymon S.; Batjer, H. Hunt.

In: Neurologic Clinics, Vol. 24, No. 4, 11.2006, p. 745-764.

Research output: Contribution to journalArticle

Hsieh, PC, Awad, IA, Getch, CC, Bendok, BR, Rosenblatt, SS & Batjer, HH 2006, 'Current Updates in Perioperative Management of Intracerebral Hemorrhage', Neurologic Clinics, vol. 24, no. 4, pp. 745-764. https://doi.org/10.1016/j.ncl.2006.05.005
Hsieh, Patrick C. ; Awad, Issam A. ; Getch, Christopher C. ; Bendok, Bernard R. ; Rosenblatt, Szymon S. ; Batjer, H. Hunt. / Current Updates in Perioperative Management of Intracerebral Hemorrhage. In: Neurologic Clinics. 2006 ; Vol. 24, No. 4. pp. 745-764.
@article{d1d45fc34899402d88595de454a8b64d,
title = "Current Updates in Perioperative Management of Intracerebral Hemorrhage",
abstract = "Spontaneous ICH remains a formidable disease that continues to disable and kill the majority of its victims. Treatment of the disease continues to be controversial and without any proved success, such as improvement in the disease mortality or the resulting disability in survivors. Primary prevention is the most effective medical intervention. Nevertheless, as the population continues to age and patients remain undertreated for hypertension, the incidence of ICH likely will increase, resulting in significant socioeconomic impact on society in the coming years. It is imperative that more research be conducted to improve treatment and outcomes of patients who have ICH. Unlike ischemic stokes or other causes of hemorrhagic stroke, such as SAH, where major advancement of treatment has led to improved outcomes, the increased incidence of ICH has not been matched with any considerable improvement in treatment. This burden to improve therapeutic interventions for patients who have ICH should be shared by all neurosurgeons, stroke neurologists, and critical care physicians who care for these patients on a regular basis. It is hoped that early diagnosis and resuscitation, prevention of hematoma growth, selective surgery or minimally invasive clot evacuation, and judicious critical care and rehabilitation will combine to lessen the burden of this disease.",
author = "Hsieh, {Patrick C.} and Awad, {Issam A.} and Getch, {Christopher C.} and Bendok, {Bernard R.} and Rosenblatt, {Szymon S.} and Batjer, {H. Hunt}",
year = "2006",
month = "11",
doi = "10.1016/j.ncl.2006.05.005",
language = "English (US)",
volume = "24",
pages = "745--764",
journal = "Neurologic Clinics",
issn = "0733-8619",
publisher = "W.B. Saunders Ltd",
number = "4",

}

TY - JOUR

T1 - Current Updates in Perioperative Management of Intracerebral Hemorrhage

AU - Hsieh, Patrick C.

AU - Awad, Issam A.

AU - Getch, Christopher C.

AU - Bendok, Bernard R.

AU - Rosenblatt, Szymon S.

AU - Batjer, H. Hunt

PY - 2006/11

Y1 - 2006/11

N2 - Spontaneous ICH remains a formidable disease that continues to disable and kill the majority of its victims. Treatment of the disease continues to be controversial and without any proved success, such as improvement in the disease mortality or the resulting disability in survivors. Primary prevention is the most effective medical intervention. Nevertheless, as the population continues to age and patients remain undertreated for hypertension, the incidence of ICH likely will increase, resulting in significant socioeconomic impact on society in the coming years. It is imperative that more research be conducted to improve treatment and outcomes of patients who have ICH. Unlike ischemic stokes or other causes of hemorrhagic stroke, such as SAH, where major advancement of treatment has led to improved outcomes, the increased incidence of ICH has not been matched with any considerable improvement in treatment. This burden to improve therapeutic interventions for patients who have ICH should be shared by all neurosurgeons, stroke neurologists, and critical care physicians who care for these patients on a regular basis. It is hoped that early diagnosis and resuscitation, prevention of hematoma growth, selective surgery or minimally invasive clot evacuation, and judicious critical care and rehabilitation will combine to lessen the burden of this disease.

AB - Spontaneous ICH remains a formidable disease that continues to disable and kill the majority of its victims. Treatment of the disease continues to be controversial and without any proved success, such as improvement in the disease mortality or the resulting disability in survivors. Primary prevention is the most effective medical intervention. Nevertheless, as the population continues to age and patients remain undertreated for hypertension, the incidence of ICH likely will increase, resulting in significant socioeconomic impact on society in the coming years. It is imperative that more research be conducted to improve treatment and outcomes of patients who have ICH. Unlike ischemic stokes or other causes of hemorrhagic stroke, such as SAH, where major advancement of treatment has led to improved outcomes, the increased incidence of ICH has not been matched with any considerable improvement in treatment. This burden to improve therapeutic interventions for patients who have ICH should be shared by all neurosurgeons, stroke neurologists, and critical care physicians who care for these patients on a regular basis. It is hoped that early diagnosis and resuscitation, prevention of hematoma growth, selective surgery or minimally invasive clot evacuation, and judicious critical care and rehabilitation will combine to lessen the burden of this disease.

UR - http://www.scopus.com/inward/record.url?scp=33748172839&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33748172839&partnerID=8YFLogxK

U2 - 10.1016/j.ncl.2006.05.005

DO - 10.1016/j.ncl.2006.05.005

M3 - Article

C2 - 16935200

AN - SCOPUS:33748172839

VL - 24

SP - 745

EP - 764

JO - Neurologic Clinics

JF - Neurologic Clinics

SN - 0733-8619

IS - 4

ER -